Biopharmaceutical research companies are conducting or have conducted more than 2,000 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the more than 2,000 clinical trials, more than 1,000 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
“Clinical trials research is imperative for finding the next treatments and cures for costly chronic diseases and conditions. The 2012 cost for caring for individuals with Alzheimer’s disease in the U.S. is estimated at $200 billion. By 2050 costs are estimated to rise to $1.1 trillion (in today’s dollars) if a cure or more effective treatments are not found. We are privileged in Wisconsin to have some of the best research universities and facilities in the world working on this problem, including the Federal Alzheimer’s Disease Research Center located at the U.W. Madison.” --Rob Gundermann, Public Policy Director, Alzheimer’s & Dementia Alliance of Wisconsin